Results 161 to 170 of about 34,488 (237)

Comparative analysis of the effects of aztreonam combined with four β-lactamase inhibitors against carbapenem-resistant <i>Enterobacterales</i>. [PDF]

Microbiol Spectr
Meng Q, Xu C, Li W, Shen K, Huang X, Fu X, Zhou L, Chen Y, Hu F, Wang H.   +9 more
europepmc   +1 more source

Synergistic Potential of Repurposing non-β-lactam Compounds as Class A serine β-lactamases Inhibitor: Insights from MolecularDocking, Molecular Dynamics Simulations and Antimicrobial Potentiation. [PDF]

Sci Rep
Abdalla MS, Dutta S, Sulieman MO, Jaber AA, Noorelhuda MO, Elkhidir OF, Sardar S, Hajhamed NM, Awad TA, Mustafa SA, Lee SG, Aldin NAM.   +11 more
europepmc   +1 more source

Emergence of KPC-producing <i>Pseudomonas aeruginosa</i> in Spain: insights into an outbreak and resistance to the novel carbapenem/β-lactamase inhibitor combinations imipenem/relebactam and meropenem/vaborbactam. [PDF]

Antimicrob Agents Chemother
Pérez-Rodríguez G, Aja-Macaya P, González-Pinto L, Taltavull B, Tarriño-León M, Gallardo-García MdM, Blanco-Martín T, Rodríguez-Pallares S, Sánchez-Peña L, Moscoso M, Beceiro A, Oliver A, Bou G, Arca-Suárez J.   +13 more
europepmc   +1 more source

Integrated machine learning, molecular dynamics, and density functional theory approaches for identifying potential inhibitor targeting TEM 𝛽-lactamase in <i>Escherichia coli</i>. [PDF]

Front Bioinform
Roy A, Anbarasu A.
europepmc   +1 more source

The Brief Case: Pneumonia in a <i>Boa constrictor occidentalis</i> with inclusion body disease caused by multidrug-resistant VIM-type metallo-β-lactamase producing <i>Pseudomonas aeruginosa</i>. [PDF]

J Clin Microbiol
Broering Ferreira A, Pilegi Sfaciotte RA, Fagundes LDEM, Peterle H, Veiga RF, Vieira S, Carneiro RK, Costa UMd, Ferraz SM.   +8 more
europepmc   +1 more source

Antibiotic resistance in odontogenic infections: A systematic review of current evidence and implications for guideline-based therapy. [PDF]

Clin Oral Investig
Schmid AI, Werkmeister R, Al-Nawas B, Heider J.   +3 more
europepmc   +1 more source

Disarming carbapenemase-producing <i>Acinetobacter baumannii</i>: high potency of the novel therapeutic combination of meropenem and the innovative diazabicyclooctane β-lactamase inhibitor pilabactam (formerly ANT3310). [PDF]

Antimicrob Agents Chemother
Rodríguez-Pallares S, Outeda-García M, Lence E, Rodríguez-Coello A, González-Pinto L, Guijarro-Sánchez P, Báez-Barroso GA, Blanco-Martín T, Vázquez-Ucha JC, Llanos A, Sannio F, Docquier J-D, Morrisey I, Hawser S, Zalacain M, Lemonnier M, González-Bello C, Bou G, Beceiro A, Arca-Suárez J.   +19 more
europepmc   +1 more source

Insights into <i>Arcanobacterium haemolyticum</i>: A Narrative Review of an Emerging Pathogen Revisited. [PDF]

Pathogens
Consonni A, Briozzo E, Giubbi C, Tonolo S, Luzzaro F, Mauri C.   +5 more
europepmc   +1 more source

Structural and Kinetic Basis for the Rational Design of Next-Generation β-Lactamase Inhibitors. [PDF]

J Med Chem
Chen S, Yu M, Xu M, Decherchi S, Taracila MA, Hujer AM, Bethel CR, Bonomo RA, Haider S.   +8 more
europepmc   +1 more source

Genes and physiological strategies in bacterial antibiotic resistance. [PDF]

Front Microbiol
Nadeem MS, Rasool R, Afzal M, Ullah I, Murtaza BN, Daoub RMA, Chaieb K, Alzarea SI, Kazmi I, Ashraf GM.   +9 more
europepmc   +1 more source